Cubist Systematic Strategies’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Cubist Systematic Strategies’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,200	Closed	-$343K	–	4979
2022 Q3	$343K	Sell	17,200 -54,976	-76%	-$725K	﹤0.01%	3445
2022 Q2	$497K	Sell	72,176 -21,070	-23%	-$148K	﹤0.01%	3067
2022 Q1	$867K	Buy	93,246 +69,486	+292%	+$740K	0.01%	2147
2021 Q4	$338K	Buy	23,760 +3,119	+15%	+$54K	﹤0.01%	2718
2021 Q3	$479K	Buy	20,641 +11,539	+127%	+$273K	0.01%	2065
2021 Q2	$227K	Buy	+9,102	New	+$245K	﹤0.01%	2482

Cubist Systematic Strategies's FMTX Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 17,200 shares — an estimated $343K sold.

Cubist Systematic Strategies first reported a position in FMTX in Q2 2021 and held it in 6 quarters. The position peaked at $867K in Q1 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Cubist Systematic Strategies reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 17,200 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $343K.
Cubist Systematic Strategies first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Cubist Systematic Strategies's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $867K in Q1 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.